Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Goodwill (2021 - 2025)

Historic Goodwill for LifeStance Health (LFST) over the last 5 years, with Q3 2025 value amounting to $1.3 billion.

  • LifeStance Health's Goodwill changed 0.0% to $1.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 billion, marking a year-over-year change of 0.0%. This contributed to the annual value of $1.3 billion for FY2024, which is 0.0% changed from last year.
  • Per LifeStance Health's latest filing, its Goodwill stood at $1.3 billion for Q3 2025, which was down 0.0% from $1.3 billion recorded in Q2 2025.
  • LifeStance Health's 5-year Goodwill high stood at $1.3 billion for Q1 2023, and its period low was $1.1 billion during Q2 2021.
  • Over the past 5 years, LifeStance Health's median Goodwill value was $1.3 billion (recorded in 2023), while the average stood at $1.3 billion.
  • Its Goodwill has fluctuated over the past 5 years, first surged by 921.96% in 2022, then dropped by 2.06% in 2024.
  • Over the past 5 years, LifeStance Health's Goodwill (Quarter) stood at $1.2 billion in 2021, then grew by 5.68% to $1.3 billion in 2022, then increased by 1.6% to $1.3 billion in 2023, then changed by 0.0% to $1.3 billion in 2024, then changed by 0.0% to $1.3 billion in 2025.
  • Its Goodwill stands at $1.3 billion for Q3 2025, versus $1.3 billion for Q2 2025 and $1.3 billion for Q1 2025.